Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives
AI Sentiment
Highly Positive
8/10
as of 12-12-2025 3:07pm EST
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 18.8M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 27.8K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -11.90 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.55 - $153.90 | Next Earning Date: | 11-14-2025 |
| Revenue: | N/A | Revenue Growth: | 50.00% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
ABP Breaking Stock News: Dive into ABP Ticker-Specific Updates for Smart Investing
AI Sentiment
Highly Positive
8/10
See how ABP stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "ABP Abpro Holdings Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.